cardiovascular conditions

Belgian Drug Firm Plans IPO in Brussels

Cardio3 BioSciences is planning an IPO after a previous unsuccessful run.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics